Prolonged epileptic seizures in children, also known as status epilepticus, represent a serious medical emergency. They require rapid intervention to prevent brain damage and other serious complications. Among the medications used, midazolam and diazepam are two common treatments, but their effectiveness varies depending on how they are administered.<\/p>\n
A recent analysis compared these two drugs in over 1,100 children suffering from prolonged seizures. The results show that midazolam is more effective in stopping seizures, especially when administered orally or intramuscularly. It also reduces the risk of treatment failure and limits seizure recurrence after the initial cessation. For example, orally administered midazolam proved superior to rectally administered diazepam, with a shorter onset time and better therapeutic success.<\/p>\n
Another advantage of midazolam is its ease of use in emergency situations, where venous access can be difficult or delayed. Indeed, inserting an IV in a child experiencing a seizure is not always straightforward and can fail in one out of four cases. Midazolam, available in oral, nasal, or intramuscular formulations, allows for rapid action without requiring specialized equipment. This makes it a preferred option for prehospital care or in environments with limited resources.<\/p>\n
In terms of safety, both drugs have similar profiles, particularly regarding the risk of respiratory depression, a feared side effect of benzodiazepines. No significant difference was observed between midazolam and diazepam on this point, which reinforces confidence in using midazolam as a first-line treatment.<\/p>\n
Midazolam acts quickly due to its ability to easily cross the blood-brain barrier, allowing for faster seizure control. Its short metabolism also reduces the risk of accumulation in the body, a problem sometimes encountered with diazepam, whose slower elimination can lead to prolonged sedation or interactions with other medications.<\/p>\n
These findings confirm international recommendations that already position midazolam as the treatment of choice for prolonged seizures in children. They also highlight the importance of adapting medical protocols to favor non-intravenous routes of administration, which are more practical and equally effective. This could improve the management of children, especially in situations where every minute counts.<\/p>\n
The studies included in this analysis cover children of different ages and backgrounds, which strengthens the reliability of the conclusions. However, additional research could refine these results, particularly regarding long-term effects or specific contexts. For now, the available evidence clearly supports the use of midazolam, especially via oral or intramuscular routes, as the best choice for rapidly and effectively treating prolonged epileptic seizures in children.<\/p>\n
DOI:<\/strong> https:\/\/doi.org\/10.1038\/s41390-025-04722-6<\/a><\/p>\n Title:<\/strong> Efficacy, safety, route of administration of midazolam and diazepam for pediatric status epilepticus: systematic review, meta-analysis, and trial sequential analysis<\/p>\n Journal:<\/strong> Pediatric Research<\/p>\n Publisher:<\/strong> Springer Science and Business Media LLC<\/p>\n Authors:<\/strong> Ahmed Kertam; Nourhan Hatem; Omar Mahmood AL-AZZAWI; Long. H. Tu; Ahmed Harb; Mohamed Sabri Hassanin; Israa Abdeen; Mariam Mostafa; Salma Allam; Mohamed Mostafa; Yehia Nabil<\/p>\n","protected":false},"excerpt":{"rendered":" Is midazolam more effective than diazepam in stopping epileptic seizures in children? Prolonged epileptic seizures in children, also known as status epilepticus, represent a serious medical emergency. They require rapid intervention to prevent brain damage and other serious complications. Among the medications used, midazolam and diazepam are two common treatments, but their effectiveness varies depending… Continue reading Is midazolam more effective than diazepam in stopping epileptic seizures in children?<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-45","post","type-post","status-publish","format-standard","hentry","category-health","entry"],"_links":{"self":[{"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/posts\/45","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/comments?post=45"}],"version-history":[{"count":1,"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/posts\/45\/revisions"}],"predecessor-version":[{"id":46,"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/posts\/45\/revisions\/46"}],"wp:attachment":[{"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/media?parent=45"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/categories?post=45"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/internationalsciencereview.com\/en\/wp-json\/wp\/v2\/tags?post=45"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}